Abstract | OBJECTIVE: METHODS: Two hundred ninety-six patients with RA were enrolled (cases) and 120 healthy individuals served as controls. The genotypes of MTHFR C667T and A1298C SNP and RFC-1 A80G SNP were detected by restriction fragment length polymorphism-PCR and compared between cases and controls. We analyzed correlations of clinical effect, toxicity, and SNPs after 6 months of MTX treatment. RESULTS: We detected no significant differences in MTHFR C677T and A1298C and RFC-1 A80G SNPs between cases and controls. The RFC-1 A80G SNP differed between RA patients with good and poor efficacy after 6 months of MTX, and was an independent factor of MTX efficacy. The MTHFR C677T SNP was differently distributed in the adverse drug reaction (ADR) and non-ADR groups and was an independent factor of MTX toxicity. CONCLUSIONS: In Chinese Han patients with RA, the MTHFR C667T SNP may correlate with MTX toxicity, whereas the RFC-1 A80G SNP may correlate with MTX efficacy rather than toxicity.
|
Authors | Shengli Wang, Shuguang Zuo, Zhigang Liu, Xinying Ji, Zhenqiang Yao, Xinchun Wang |
Journal | The Journal of international medical research
(J Int Med Res)
Vol. 48
Issue 2
Pg. 300060519879588
(Feb 2020)
ISSN: 1473-2300 [Electronic] England |
PMID | 31617429
(Publication Type: Journal Article)
|
Chemical References |
- Antirheumatic Agents
- MTHFR protein, human
- Methylenetetrahydrofolate Reductase (NADPH2)
- Methotrexate
|
Topics |
- Antirheumatic Agents
(adverse effects)
- Arthritis, Rheumatoid
(drug therapy, genetics)
- China
- Genotype
- Humans
- Methotrexate
(adverse effects)
- Methylenetetrahydrofolate Reductase (NADPH2)
(genetics)
- Polymorphism, Single Nucleotide
(genetics)
|